Cetilistat - Investigational Drug for Obesity


Figures from the American Heart Association suggest 20% to 25% of US adults have metabolic syndrome, for which obesity is a contributory factor.

  • Metabolic syndrome
  • Obesity contributory factors
  • Clinical obesity
  • UK rates of obesity
  • Lipase inhibitors


| 1 | 2 | 3 | 4 | 5 |

Browse More Images - Return to Project




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
Features
White Papers
Jobs & Careers
Industry News
Gallery
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development